Moderna’s mFlusiva is the seasonal influenza shot that replaces the traditional egg-grown or cell-grown virus protein with a ...

For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...

Siladitya Ray is a New Delhi-based Forbes news team reporter. In a statement, vaccine maker Moderna said its “mFLUSIVA” vaccine against seasonal influenza has been approved for use by all adults aged ...

mRNA flu shots have officially arrived. On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots. The flu ...

The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu vaccines. On August 5, the US Food and Drug Administration approved ...

The U.S.-approved vaccine — faster to produce and more precise than traditional flu shots — is awaiting the green light in Canada ...

This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the ...